Barclays’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
23
| – | – | ﹤0.01% | 4521 |
|
|
2025
Q1 | $0 | Sell |
23
-77
| -77% | – | ﹤0.01% | 4523 |
|
|
2024
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 4469 |
|
|
2024
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 4413 |
|
|
2024
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 4288 |
|
|
2024
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 4258 |
|
|
2023
Q4 | $0 | Sell |
100
-100
| -50% | – | ﹤0.01% | 4312 |
|
|
2023
Q3 | $0 | Buy |
200
+100
| +100% | – | ﹤0.01% | 4357 |
|
|
2023
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 4376 |
|
|
2023
Q1 | $0 | Buy |
+100
| New | – | ﹤0.01% | 4388 |
|
|
2022
Q3 | – | Sell |
-1,000
| Closed | -$2K | – | 4789 |
|
|
2022
Q2 | $2K | Sell |
1,000
-3,319
| -77% | -$6.64K | ﹤0.01% | 4578 |
|
|
2022
Q1 | $26K | Sell |
4,319
-21,729
| -83% | -$131K | ﹤0.01% | 4241 |
|
|
2021
Q4 | $329K | Buy |
26,048
+17,795
| +216% | +$225K | ﹤0.01% | 2681 |
|
|
2021
Q3 | $756K | Buy |
8,253
+5,551
| +205% | +$508K | ﹤0.01% | 2399 |
|
|
2021
Q2 | $143K | Sell |
2,702
-10,623
| -80% | -$562K | ﹤0.01% | 3017 |
|
|
2021
Q1 | $480K | Buy |
13,325
+7,963
| +149% | +$287K | ﹤0.01% | 2672 |
|
|
2020
Q4 | $149K | Sell |
5,362
-1,836
| -26% | -$51K | ﹤0.01% | 2837 |
|
|
2020
Q3 | $360K | Sell |
7,198
-1,452
| -17% | -$72.6K | ﹤0.01% | 2464 |
|
|
2020
Q2 | $400K | Buy |
8,650
+4,817
| +126% | +$223K | ﹤0.01% | 2455 |
|
|
2020
Q1 | $175K | Sell |
3,833
-8,280
| -68% | -$378K | ﹤0.01% | 2603 |
|
|
2019
Q4 | $680K | Buy |
12,113
+10,539
| +670% | +$592K | ﹤0.01% | 2519 |
|
|
2019
Q3 | $39K | Sell |
1,574
-4,384
| -74% | -$109K | ﹤0.01% | 3737 |
|
|
2019
Q2 | $253K | Buy |
+5,958
| New | +$253K | ﹤0.01% | 3079 |
|